Therapeutic drug monitoring: Perspectives of psychiatrists in Turkey

References

• Aynacıoglu AŞ. 2001. Psikiyatrik Hastalıkların İlaçlarla Tedavisinde Farmakogenetiğin Önemi. (Importance of pharmacogenetics in pharmacotherapy of psychiatric disorders) Klinik Psikiyatri 4: 249–252.(Turkish)
   Google Scholar
• Baumann P, Hiemke C, Ulrich S, Eckermann G, Kuss HL, Laux G, et al. 2006. Le dosage plasmatique des médicaments psychotropes à des fins thérapeutiques: recommandations du groupe d'experts AGNP-TDM. Rev Med Suisse 2:1413–1418.
   PubMedGoogle Scholar
• Birkett DJ. 1997. Pharmacokinetics made easy: therapeutic drug monitoring. Aust Prescr 20:9–11.
   Google Scholar
• Conca A, Schmidt E, Pastore M, Hiemke C, Duffy D, Giupponi G. 2011. Therapeutic drug monitoring in Italian psychiatry. Pharmacopsychiatry 44:259–262.
   PubMed Web of Science ®Google Scholar
• Coutts RT, Urichuk LJ. 1999. Polymorphic cytochromes P450 and drugs used in psychiatry. Cell Mol Neurobiol 19:325–354.
   PubMedGoogle Scholar
• De Leon J, Armstrong SC, Cozza KL. 2006. Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19. Psychosomatics 47:75–85.
   PubMed Web of Science ®Google Scholar
• De Leon J. 2007. The crucial role of the therapeutic window in understanding the clinical relevance of the poor versus the ultrarapid metabolizer phenotypes in subjects taking drugs metabolized by CYP2D6 or CYP2C19. J Clin Psychopharmacol 27: 241–245.
   PubMed Web of Science ®Google Scholar
• Gervasini G, Benítez J, Carrillo JA. 2010. Pharmacogenetic testing and therapeutic drug monitoring are complementary tools for optimal individualization of drug therapy. Eur J Clin Pharmacol 66: 755–774.
   PubMed Web of Science ®Google Scholar
• Guo W, Guo GX, Sun C, Zhang J, Rong Z, He J, et al. 2013. Therapeutic drug monitoring of psychotropic drugs in China: A nationwide survey. Ther Drug Monit 35:816–822.
   PubMedGoogle Scholar
• Herken H, Aynacıoğlu Ş, Esgi K, Virit O. 2001. Psikiyatri Hastalarında Sitokrom P450 2D6 Yavaş ve Ultra Hızlı Metabolizör Sıklıkları.(Frequency of cyp p4502D6slow and ultrarapid metabolizer rates in psychiatric patients) Türk Psikiyatri Dergisi 12:83–88. (Turkish)
   Google Scholar
• Hiemke C, Shams M. 2013. Phenotyping and genotyping of drug metabolism to guide pharmacotherapy in psychiatry. Curr Drug Deliv 10:46–53.
   PubMedGoogle Scholar
• Hiemke C, Baumann P, Bergemann N, Conca A, Dietmaier O, Egberts K, et al. 2011. AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: Update 2011 zernig. Pharmacopsychiatry 44:195–235.
   Web of Science ®Google Scholar
• Ingelman-Sundberg M. 2001. Pharmacogenetics: an opportunity for a safer and more efficient pharmacotherapy. J Intern Med 250:186–200.
   PubMed Web of Science ®Google Scholar
• Jaquenoud Sirot E, van der Velden JW, Rentsch K, Eap CB, Baumann P. 2006. Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance. Drug Saf 29:735–768.
   PubMed Web of Science ®Google Scholar
• Kirchheiner J, Nickchen K, Bauer M, Wong ML, Licinio J, Roots I, Brockmöller J. 2004. Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response. Mol Psychiatry 9:442–473.
   PubMed Web of Science ®Google Scholar
• Lundmark J, Bengtsson F, Nordin C, Reis M, Wålinder J. 2000. Therapeutic drug monitoring of selective serotonin reuptake inhibitors influences clinical dosing strategies and reduces drug costs in depressed elderly patients. Acta Psychiatr Scand 101: 354–359.
   PubMed Web of Science ®Google Scholar
• Mandrioli R, Mercolini L, Saracino MA, Raggi MA. 2012. Selective serotonin reuptake inhibitors (SSRIs): Therapeutic drug monitoring and pharmacological interactions. Curr Med Chem 19: 1846–1863.
   PubMed Web of Science ®Google Scholar
• Müller MJ, Dragicevic A, Fric M, Gaertner I, Grasmäder K, Härtter S, et al. 2003. Therapeutic drug monitoring of tricyclic antidepressants: how does it work under clinical conditions? Pharmacopsychiatry 36:98–104.
   PubMed Web of Science ®Google Scholar
• Preskorn SH, Fast GA. 1991. Therapeutic drug monitoring for antidepressants: efficacy, safety, and cost effectiveness. J Clin Psychiatry 52:23–33.
   PubMed Web of Science ®Google Scholar
• Touw DJ, Neef C, Thomson AH, Vinks AA. 2005. Cost-effectiveness of therapeutic drug monitoring: a systemic review. Ther Drug Monit 27:10–17.
   PubMed Web of Science ®Google Scholar
• Vuille F, Amey M, Baumann P. 1991. Use of plasma level monitoring of antidepressants in clinical practice. Towards an analysis of clinical utility. Pharmacopsychiatry 24:190–195.
   Google Scholar